Viewing Study NCT01460134


Ignite Creation Date: 2025-12-25 @ 2:19 AM
Ignite Modification Date: 2025-12-27 @ 11:03 PM
Study NCT ID: NCT01460134
Status: COMPLETED
Last Update Posted: 2018-01-31
First Post: 2011-10-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic Cancers
Sponsor: Celldex Therapeutics
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module